Table 1.
Clinical Parameters of ICCA and HL.
| ICCA (N = 101) | HL (N = 28) | ||
|---|---|---|---|
| Age | 58.2 ± 10.8 | 53.2 ± 17.9 | |
| Sex (M: F) | 55: 46 | 17: 11 | |
| Size | |||
| <5 cm | 24 | NA | |
| 5 to 10 cm | 71 | ||
| >10 cm | 6 | ||
| Differentiated degree | |||
| Poorly differentiated | 26 | NA | |
| Medium to low differentiated | 54 | ||
| Medium differentiated | 19 | ||
| Medium to high differentiated | 2 | ||
| Stage | PHL (N = 8) | SHL (N = 20) | |
| II | NA | 1 | 1 |
| III | 1 | ||
| IV | 25 | ||
Abbreviations: ICCA, intrahepatic cholangiocarcinoma; HL, hepatic lymphoma; M: F male: female; NA, not appropriate; PHL, primary hepatic lymphoma; SHL, secondary hepatic lymphoma.